Pharma Logistics White Papers & Articles
-
Integrating Clinical Supply Systems & Outsourced Service Providers Whitepaper
4/28/2011
Pharmaceutical and biotech companies of all sizes are increasingly turning to third parties to execute some or all of their clinical supply activities.
-
Mastering The Extended Clinical Supply Chain Whitepaper: Strategic Advantages For Clinical Trials
4/28/2011
The core of any good clinical supply chain system is a supply management system that addresses all of the nuances of clinical supplies.
-
Article: Ask The Board
4/15/2011
One way to do so is to implement strategies that accelerate milestones. Development must get to decision points more quickly, use fewer subjects, and spend less money. Plans need to be built to ask the key questions early in validating a drug concept, investigating those issues that lead to quick go/no-go decision points. By Life Science Leader magazine
-
Government And Industry Come Together To Stop $75B Drug Counterfeit Ring
4/15/2011
Anticounterfeiting specialists believe that medicine counterfeiting is expected to increase this year, according to a survey by Pharma IQ. By Cindy Dubin
-
Article: Cold Chain Pharmaceuticals Worth Billions
4/13/2011
There is a growing global demand for increasingly complex drugs and pharmaceutical products, a market that will grow to U.S. $900B by 2012 and $1.2T by 2014. By American Airlines Cargo
-
Improving Pharmaceutical Manufacturing Regulatory Risk
3/15/2011
Pharmaceutical manufacturers must manage regulatory risk to ensure products are developed and produced in manner consistent with organizational goals and strategic objectives. Ongoing operations and marketplace supply can be hindered if a producer is not keenly aware of the regulatory environment and potential risks of underperforming processes. Operational requirements for development of clinical supply may also be adversely affected when regulatory issues exist. Similarly, drug development may be hindered by poorly performing production processes for managing laboratory testing, facilities and systems, quality and packaging/labeling. By ACSYS, Inc.
-
Balancing Effective Cold Chain Strategies Across The Supply Chain
9/27/2010
The “cold chain” is simply a supply chain with temperature requirements factored in. Cold chain (or, in some contexts, “cool chain”) encompasses the container of the product being shipped, the storage facilities (from point of manufacture to point of dispensation), and the transportation modes (air, ground, ocean). By DDN
-
Article: Improving Pharmaceutical Manufacturing Regulatory Risk
3/15/2010
Pharmaceutical manufacturers must manage regulatory risk to ensure products are developed and produced in manner consistent with organizational goals and strategic objectives. Ongoing operations and marketplace supply can be hindered if a producer is not keenly aware of the regulatory environment and potential risks of underperforming processes. Operational requirements for development of clinical supply may also be adversely affected when regulatory issues exist. Similarly, drug development may be hindered by poorly performing production processes for managing laboratory testing, facilities and systems, quality and packaging/labeling. By ACSYS, Inc.
-
Infrastructure Investments, Innovation Accelerate Biologics Development
Keeping pace with the market dynamics transforming the biologics space requires a focus on innovation and access to the integrated resources necessary to support it.
-
Improving The Supply Of Single-Use Technologies
The use of single-use technologies has been growing steadily over the past decade, but there are still challenges that remain. Explore potential solutions for single-use supply constraints.